Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.
Clin Infect Dis
; 38(5): 731-6, 2004 Mar 01.
Article
en En
| MEDLINE
| ID: mdl-14986259
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Rifamicinas
/
Tuberculosis
/
Farmacorresistencia Bacteriana
/
Antituberculosos
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Clin Infect Dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2004
Tipo del documento:
Article